Novartis Pays $370M for Drug-pushing Scheme

Blog Novartis Pays $370M for Drug-pushing Scheme

Posted on November 23, 2015

NEW YORK — Novartis Pharmaceuticals, the maker of Excederin, Ritalin and other popular drugs, agreed to pay $370 million for providing kickbacks to pharmacies to push its drugs on patients.

"*" indicates required fields

Name*

First Last

Phone Number*

Email Address*

How can we help you?*

Phone (Robots)

This field is for validation purposes and should be left unchanged.

Drug Cost
Medical Malpractice
New Drug
News
Product Liability
Unsafe Products and Medications
Workers' Compensation

1370 RXR Plaza
Uniondale, NY 11556

Attorney Advertising

Disclaimer

Website developed in accordance with Web Content Accessibility Guidelines 2.1.
If you encounter any issues while using this site, please contact us: 516.579.6500